Reports showed that prostate tumors from patients of either European, African, or Asian descent exhibit notable differences in acquired chromosomal aberrations (e.g., ERG fusion and PTEN loss) and subtype distribution [6,7,8,9], indicating disparities in disease etiology and mutational events among these population groups. Here, PTEN is linked to prostate neoplasm.